Clinical trials
Recruiting Pancreatic Neoplasms trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
36 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 4 |
| 2023 | 3 |
| 2024 | 6 |
| 2025 | 8 |
| 2026 | 8 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 36 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Imperial College London | 4 |
| Cancer Research UK | 3 |
| Revolution Medicines, Inc. | 3 |
| AstraZeneca | 2 |
| Pfizer | 2 |
| Apollomics Inc. | 1 |
| Arbor Research Collaborative for Health | 1 |
| Astellas Pharma Global Development, Inc. | 1 |
| Auricula Biosciences Inc. | 1 |
| Cambridge University Hospitals NHS Foundation Trust | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pancreatic Neoplasms | 36 |
| Esophageal Neoplasms | 10 |
| Urinary Bladder Neoplasms | 10 |
| Stomach Neoplasms | 9 |
| Colorectal Neoplasms | 8 |
| Ovarian Neoplasms | 8 |
| Carcinoma, Non-Small-Cell Lung | 7 |
| Lung Neoplasms | 6 |
| Neoplasm Metastasis | 6 |
| Neoplasms | 6 |
Trials
Showing 1 to 25 of 36. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.